Shuhei Shinoda

Deferasirox, a novel oral iron chelator, shows antiproliferative activity against pancreatic cancer in vitro and in vivo

Hirofumi Harima, Seiji Kaino, Taro Takami et al. · BMC Cancer · 2016 · 59 citations · Full text

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth<i>in vitro</i>and<i>in vivo</i>

Shuhei Shinoda, Seiji Kaino, Shogo Amano et al. · Oncotarget · 2018 · 32 citations · Full text

RETRACTED ARTICLE: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

Shogo Amano, Seiji Kaino, Shuhei Shinoda et al. · BMC Cancer · 2020 · 25 citations · Full text

Intracellular colocalization of HAP1/STBs with steroid hormone receptors and its enhancement by a proteasome inhibitor

Ryutaro Fujinaga, Yukio Takeshita, Kazuhiro Yoshioka et al. · Experimental Cell Research · 2011 · 15 citations

Protein Function, Signal Transduction, Biochemistry +14

Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2

Keith M. Wirth, Shuhei Shinoda, Mizuho Sato‐Dahlman et al. · Surgery for Obesity and Related Diseases · 2021 · 13 citations · Full text

Signaling Pathway, Pancreatic Cancer, Medicine +8